A carregar...
Bortezomib-induced severe pulmonary complications in multiple myeloma: A case report and literature review
The proteasome inhibitor bortezomib is indicated for use in the treatment of multiple myeloma (MM) patients. The most common side effects are neurological and gastrointestinal, while severe pulmonary complications are rarely described. The present study reports the case of a 62-year-old man with imm...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774611/ https://ncbi.nlm.nih.gov/pubmed/26998158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4204 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|